HomeInsightsPE

Sun Pharma Advanced Research Company Ltd PE Ratio

Sun Pharma Advanced Research Company Ltd PE Ratio

stocks purchased

₹ 0.8 Cr

Volume transacted

stocks purchased

37.6 K

stocks traded

Last Updated time: 07 Oct 15:30 PM

Image

Sun Pharma Advanced Research Company Ltd

NSE: SPARC

PE

0

Last updated: 07 Oct 15:30 PM

Key Highlights

  • The P/E Ratio of Sun Pharma Advanced Research Company Ltd is 0 as of 07 Oct 15:30 PM.
  • The P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from 0 on March 2023 to 0 on March 2024 . This represents a CAGR of 0.0% over 2 years. .
  • The Latest Trading Price of Sun Pharma Advanced Research Company Ltd is ₹ 202.05 as of 07 Oct 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Sun Pharma Advanced Research Company Ltd

No data available

Company Fundamentals for Sun Pharma Advanced Research Company Ltd

No data available

Image

Sun Pharma Advanced Research Company Ltd

NSE: SPARC

PRICE

202.05

-8.20 (-3.90%)

stock direction

Last updated: 07 Oct 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Sun Pharma Advanced Research Company Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
07 Oct 2024202.05
04 Oct 2024210.25
03 Oct 2024209.45
01 Oct 2024215.95
30 Sep 2024215.9
27 Sep 2024212.35
26 Sep 2024212.65
25 Sep 2024216.25
24 Sep 2024219.25
23 Sep 2024217.65

SWOT Analysis Of Sun Pharma Advanced Research Company Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Sun Pharma Advanced Research Company Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sun Pharma Advanced Research Company Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Sun Pharma Advanced Research Company Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical Revenue of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in crore

Historical Dividend Payout of Sun Pharma Advanced Research Company Ltd

No data available

* All values are in %

About Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
  • The Company works on innovation and new product development for global markets.
  • They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS).
  • Sun Pharmaceutical Advanced Research Company Ltd was incorporated on March 1, 2006 as an innovative and development company.
  • They commenced operations on March 22, 2006.

Sun Pharma Advanced Research Company Ltd News Hub

News

Sun Pharma Advanced Research Company announces board meeting date

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

30 Jul 202411:28

News

Sun Pharma Advanced Research Company to conduct AGM

Sun Pharma Advanced Research Company announced that the 19th Annual General Meeting (AGM) ...

Read more

09 Jul 202412:07

News

SPARC CFO Chetan Rajpara resigns

Rajpara stated that he wants to pursue his ambition and personal goals, which would involv...

Read more

06 Jun 202412:43

News

Sun Pharma Advanced Research Company to hold board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

17 May 202416:47

News

Volumes jump at Sun Pharma Advanced Research Company Ltd counter

Jupiter Wagons Ltd, Kotak Mahindra Bank Ltd, Jyothy Labs Ltd, Godfrey Phillips India Ltd a...

Read more

25 Apr 202414:30

News

Sun Pharma Advanced Research Company Ltd Slides 5%

Sun Pharma Advanced Research Company Ltd lost 5% today to trade at Rs 409.55. The S&P BSE ...

Read more

12 Apr 202409:30

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Sun Pharma Advanced Research Company Ltd

What is the current PE Ratio of Sun Pharma Advanced Research Company Ltd?

The Current PE Ratio of Sun Pharma Advanced Research Company Ltd is 0.0 as on 7 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 7 Oct 2024.

What was the PE Ratio of Sun Pharma Advanced Research Company Ltd last year?

The PE Ratio of Sun Pharma Advanced Research Company Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Sun Pharma Advanced Research Company Ltd indicate about its stock?

The PE Ratio of Sun Pharma Advanced Research Company Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Sun Pharma Advanced Research Company Ltd.

What is the PE Ratio Growth of Sun Pharma Advanced Research Company Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sun Pharma Advanced Research Company Ltd grew by -% whereas, the EPS ratio grew by -9.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*